Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?
作者信息
Lanier William L
出版信息
Mayo Clin Proc. 2009 Sep;84(9):771-5. doi: 10.4065/84.9.771.
Abstract
摘要
相似文献
1
Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity?涉及行业与医学期刊的双向利益冲突：谁将捍卫诚信？
Mayo Clin Proc. 2009 Sep;84(9):771-5. doi: 10.4065/84.9.771.
2
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.与行业相关的科学出版物中的利益冲突、作者身份及信息披露：侵权律师与医学期刊的编辑监督
Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811.
3
[The journals must honestly tell who is doing the job].这些期刊必须诚实地说明是谁在做这项工作。
Lakartidningen. 2008;105(19):1406-7.
4
[Knowledge on feet of clay].[徒有其表的知识]
Lakartidningen. 2008;105(19):1405-6.
5
The sins of ghostwriting.代笔的罪过。
Am J Ther. 2008 Jul-Aug;15(4):297-8. doi: 10.1097/MJT.0b013e318180f387.
6
How honest can a medical journal be?医学期刊能有多诚实？
Aust N Z J Obstet Gynaecol. 2006 Feb;46(1):2-3. doi: 10.1111/j.1479-828X.2006.00505.x.
7
Ghostwriters in the fray: the implications for science, industry, medical journals, and our patients.卷入纷争的代笔作者：对科学、产业、医学期刊及我们患者的影响
Adv Skin Wound Care. 2009 Nov;22(11):494-6. doi: 10.1097/01.ASW.0000363462.31578.37.
8
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):196; author reply 201-4. doi: 10.4065/mcp.2009.0610.
9
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):200-1. doi: 10.4065/mcp.2009.0595.
10
[Ghostwriting].（代笔）
Tidsskr Nor Laegeforen. 2008 May 1;128(9):1039.
引用本文的文献
1
Reading Between the Lines: Navigating Nuance in Medical Literature to Optimize Clinical Decision-Making and Health Care Outcomes.字里行间的解读：在医学文献中把握细微差别以优化临床决策和医疗保健结果。
Adv Med Educ Pract. 2023 Oct 19;14:1167-1176. doi: 10.2147/AMEP.S427663. eCollection 2023.
2
Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.欧洲心脏病学会国家心血管期刊的利益冲突政策和披露要求。
Neth Heart J. 2012 Jun;20(6):279-87. doi: 10.1007/s12471-012-0277-7.
3
Ten recommendations for closing the credibility gap in reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry perspective.缩小行业资助临床研究报告中可信度差距的十条建议：期刊与制药行业联合视角
Mayo Clin Proc. 2012 May;87(5):424-9. doi: 10.1016/j.mayocp.2012.02.009.
4
Myelodysplastic syndromes--many new drugs, little therapeutic progress.骨髓增生异常综合征——新药众多，治疗进展甚微。
Mayo Clin Proc. 2010 Nov;85(11):1042-5. doi: 10.4065/mcp.2010.0502. Epub 2010 Sep 22.
5
Professional medical organizations and commercial conflicts of interest: ethical issues.专业医学组织与商业利益冲突：伦理问题。
Ann Fam Med. 2010 Jul-Aug;8(4):354-8. doi: 10.1370/afm.1140.
6
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):200-1. doi: 10.4065/mcp.2009.0595.
7
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):199-200; author reply 201-4. doi: 10.4065/mcp.2009.0744.
8
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况
Mayo Clin Proc. 2010 Feb;85(2):197-9; author reply 201-4. doi: 10.4065/mcp.2009.0559.
9
Conflicts of interest, authorship, and disclosures in industry-related scientific publications.与行业相关的科学出版物中的利益冲突、作者身份及披露情况。
Mayo Clin Proc. 2010 Feb;85(2):196; author reply 201-4. doi: 10.4065/mcp.2009.0610.
本文引用的文献
1
Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals.与行业相关的科学出版物中的利益冲突、作者身份及信息披露：侵权律师与医学期刊的编辑监督
Mayo Clin Proc. 2009 Sep;84(9):811-21. doi: 10.4065/84.9.811.
2
Impugning the integrity of medical science: the adverse effects of industry influence.质疑医学科学的诚信：行业影响的不良后果。
JAMA. 2008 Apr 16;299(15):1833-5. doi: 10.1001/jama.299.15.1833.
3
Time to nip "seeding trials" in the bud.
Arch Dermatol. 2008 Mar;144(3):403-4. doi: 10.1001/archderm.144.3.403.
4
Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?幽灵作者现象：医药行业在幕后对医学文献的影响究竟有多大？
PLoS Med. 2007 Sep;4(9):e286. doi: 10.1371/journal.pmed.0040286.
5
[Clinical trial registration: looking back and moving ahead].[临床试验注册：回顾与展望]
Ugeskr Laeger. 2007 Jun 25;169(26):2505-6.
6
Divergent views on managing clinical conflicts of interest.关于管理临床利益冲突的不同观点。
Mayo Clin Proc. 2007 Aug;82(8):1013-4; author reply 1014-5. doi: 10.4065/82.8.1013.
7
Clinical trial registration: looking back and moving ahead.临床试验注册：回顾与展望。
Croat Med J. 2007 Jun;48(3):289-91.
8
Clinical trial registration: looking back and moving ahead.临床试验注册：回顾与展望。
N Z Med J. 2007 Jun 15;120(1256):U2586.
9
Clinical trial registration: looking back and moving ahead.临床试验注册：回顾与展望。
Med J Aust. 2007 Jun 18;186(12):612-3. doi: 10.5694/j.1326-5377.2007.tb01074.x.
10
Clinical trial registration: looking back and moving ahead.临床试验注册：回顾与展望。
Lancet. 2007 Jun 9;369(9577):1909-11. doi: 10.1016/S0140-6736(07)60894-0.
Zotero 插件